+1,136.4%
MPC vs GSK
+107.3%
+1,029.1%
-79.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.0% | -0.1% | -2.9% | -3.0% |
| 7D | +3.2% | -1.3% | +4.5% | +3.6% |
| 30D | -15.9% | +2.7% | -18.6% | -16.9% |
| 3M | +13.5% | +2.7% | +10.8% | +11.7% |
| 6M | +58.7% | +3.3% | +55.4% | +54.6% |
| YTD | +150.2% | +6.5% | +143.7% | +136.6% |
| 1Y | +104.5% | +10.7% | +93.8% | +89.8% |
| 3Y | +192.5% | +64.4% | +128.1% | +111.0% |
| 5Y | +587.3% | +46.7% | +540.6% | +412.3% |
| 10Y | +1,136.4% | +109.4% | +1,027.0% | +659.7% |
| All | +1,136.4% | +107.3% | +1,029.1% | +659.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling